The results of this simulation model suggest that implementing a pharmacist-led medication reconciliation intervention at hospital discharge could be cost-saving compared with usual care.
Steven Kymes, PhD
Advertisement
Articles by Steven Kymes, PhD
Treatment of glaucoma with bimatoprost is associated with cost savings compared with treatment with latanoprost or travoprost because of greater intraocular pressure reduction.
Advertisement
Latest Updated Articles
- Economic Value of Pharmacist-Led Medication Reconciliation for Reducing Medication Errors After Hospital Discharge
Published: October 14th 2016 | Updated:
- Cost-Offset Analysis: Bimatoprost Versus Other Prostaglandin Analogues in Open-Angle Glaucoma
Published: September 8th 2011 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Five Ways AI Is Transforming Cancer Care—and Companies That Are Making It Happen
2
Cefdinir Nearly Doubles Outpatient Uncomplicated UTI Treatment Failure Compared With Cephalexin
3
Intermountain Spans Time Zones, Cultures to Bring Oncology Care to Alaska
4
NIH F32 Grants Boost Early-Career Researchers’ Success
5
